AMTP Logo

Your Cart

Your cart is currently empty.

Longevit NA²C

Slide 1Slide 2Slide 3

Longevit NA²C

30.00

Description

NA²C

Neurotrophic Arthritis Analgesic Complete


Type: Dietary Supplement for Nervous System & Joint Support

Content: 60 Capsules

Daily Dose: 1 capsule daily with water or juice during a meal


Product Description


A specialized combination of ingredients designed to support the nervous system, joint function, and cellular energy. It also provides anti-inflammatory and antioxidant protection, ideal for those experiencing joint pain, nerve discomfort, or seeking antiaging support.


Ingredients & Benefits


  • Vitamin B1 (Thiamine) – 2 mg

Contributes to nervous system function and energy metabolism. Helps convert carbohydrates into fuel and boosts physical and mental performance.


  • Vitamin B5 (Pantothenic Acid) – 9 mg

Essential for the synthesis of coenzyme A, involved in energy production, hormone synthesis, and skin health.


  • Vitamin B6 – 3 mg

Important for neurotransmitter synthesis, supports mood, and strengthens immunity. Also contributes to inflammation reduction.


  • Vitamin B12 – 100 μg

Essential for nerve health, red blood cell production, and DNA replication. Combats fatigue and supports cognitive function.


  • Alpha Lipoic Acid – 300 mg

A powerful antioxidant that recycles other vitamins (like C and E), helps regulate blood sugar, and supports nerve health.


  • Chromium Picolinate – 0.8 mg

Helps regulate blood sugar levels and enhances insulin sensitivity, important for energy balance and metabolism.


  • Feverfew Extract – 150 mg

Traditionally used to relieve headaches and migraines, also has anti-inflammatory properties that support the musculoskeletal system.


  • Devil’s Claw Extract – 100 mg

Known for its analgesic and anti-inflammatory effects. Ideal for individuals with arthritic pain, rheumatism, or muscle discomfort.


Manufacturer: Amhes Pharma

Distribution & Availability: AMTP Co.

Email: amtp.longevity@gmail.com

Phone: +30 2610877025

EOF Notification: 40872 / 17-7-2023